Stem Point Capital LP Bristol Myers Squibb CO Transaction History
Stem Point Capital LP
- $401 Billion
- Q4 2024
A detailed history of Stem Point Capital LP transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Stem Point Capital LP holds 166,068 shares of BMY stock, worth $8.95 Million. This represents 2.34% of its overall portfolio holdings.
Number of Shares
166,068
Previous 275,303
39.68%
Holding current value
$8.95 Million
Previous $14.2 Billion
34.06%
% of portfolio
2.34%
Previous 4.26%
Shares
2 transactions
Others Institutions Holding BMY
# of Institutions
2,729Shares Held
1.57BCall Options Held
30MPut Options Held
31.7M-
Vanguard Group Inc Valley Forge, PA190MShares$10.2 Billion0.19% of portfolio
-
Black Rock Inc. New York, NY159MShares$8.55 Billion0.15% of portfolio
-
Jpmorgan Chase & CO New York, NY96MShares$5.18 Billion0.44% of portfolio
-
State Street Corp Boston, MA95.1MShares$5.13 Billion0.22% of portfolio
-
Charles Schwab Investment Management Inc San Francisco, CA60.3MShares$3.25 Billion0.65% of portfolio
About BRISTOL MYERS SQUIBB CO
- Ticker BMY
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 2,126,160,000
- Market Cap $115B
- Description
- Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...